Defying "the norm" and creating a path to a better future for patients.
Founder & CEO
Dan has experience managing therapeutic antibody projects from preclinical stage through clinical trials. He witnessed first-hand the issues surrounding today's antivenom and decided to act.
Deepankar Roy, PhD
Co-Founder & COO
Background in drug development and manufacturing, project management, and business development. Experience in Pharmaceutical space in local and global markets.
Phil Tan, PhD
Director of Scientific Research
Phil has over 15 years of industry experience, and the expertise to use our innovative platform to discover and develop better therapies for snake venoms and other toxins.
Director of Business Development
Mads is equipped with two degrees, Computer Science and Financial Math. He has experience from previous startups along with his family business in Norway. Mads administers business development, company regulations, and financial metrics.